Nanotechnology Now - Press Release: Keystone Nano Announces FDA Approval of Investigational New Drug Application for Ceraxa for the Treatment of Acute Myeloid Leukemia
| Date | 19th, Sep 2019 |
|---|---|
| Source | Nanotechnology Now - Nanotechnology Websites |
DESCRIPTION
Keystone Nano, Inc., a biopharmaceutical company focused on improving cancer treatments through the application of novel treatments and nanotechnology, announced today that the U.S. Food and Drug Admi...